1.3M
XNAS Volume
High volume+gain today
XNAS 22 May, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| James Sapirstein | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 4.23 per share. | 01 Apr 2024 | 174 | 37,105 (0%) | 0% | 4.2 | 736 | Common Stock |
| Sarah M. Romano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.23 per share. | 01 Apr 2024 | 75 | 19,111 (0%) | 0% | 4.2 | 317 | Common Stock |
| James Sapirstein | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 15 Mar 2024 | 1,887 | 37,279 (0%) | 0% | 5.0 | 9,360 | Common Stock |
| Sarah M. Romano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 15 Mar 2024 | 1,120 | 19,186 (0%) | 0% | 5.0 | 5,555 | Common Stock |
| Chaitan S. Khosla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 440 | 440 (0%) | 0% | - | Common Stock, par value $0.0001 per share | |
| Chaitan S. Khosla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 52,980 | 52,980 | - | - | Stock Option (right to buy) | |
| Chaitan S. Khosla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 140 | 140 | - | - | Series G Non-Voting Convertible Preferred Stock | |
| Jack Syage | Director, President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 4,920 | 4,920 | - | - | Series G Non-Voting Convertible Preferred Stock | |
| Jack Syage | Director, President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 15,400 | 15,400 (0%) | 0% | - | Common Stock, par value $0.0001 per share | |
| Sapirstein James | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 4.20 per share. | 12 Jan 2024 | 166 | 39,166 (0%) | 0% | 4.2 | 697 | Common Stock |
| Sarah M. Romano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.20 per share. | 12 Jan 2024 | 98 | 20,306 (0%) | 0% | 4.2 | 412 | Common Stock |
| Edward Borkowski J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 19,633 | 20,248 (0%) | 0% | 0 | Common Stock | |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 19,633 | 19,937 (0%) | 0% | 0 | Common Stock | |
| Alastair Riddell James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 19,633 | 20,240 (0%) | 0% | 0 | Common Stock | |
| Coelho Mary Theresa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 19,633 | 20,237 (0%) | 0% | 0 | Common Stock | |
| Sapirstein James | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 17,660 | 19,332 (0%) | 0% | 0 | Common Stock | |
| Sarah Romano M. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 12,614 | 13,404 (0%) | 0% | 0 | Common Stock | |
| Sapirstein James | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 20,000 | 39,332 (0%) | 0% | 0 | Common Stock | |
| Sarah M. Romano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 7,000 | 20,404 (0%) | 0% | 0 | Common Stock | |
| James Sapirstein | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.54 per share. | 03 Jul 2023 | 3,349 | 36,161 (0%) | 0% | 1.5 | 5,157 | Common Stock |
| Sarah M. Romano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.54 per share. | 03 Jul 2023 | 1,977 | 17,476 (0%) | 0% | 1.5 | 3,045 | Common Stock |
| James Sapirstein | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 03 Apr 2023 | 3,347 | 39,510 (0%) | 0% | 2.5 | 8,368 | Common Stock |
| Sarah M. Romano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 03 Apr 2023 | 1,975 | 19,453 (0%) | 0% | 2.5 | 4,938 | Common Stock |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 84,745 | 85,134 (0%) | 0% | 0 | Common Stock | |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 84,745 | 86,156 (0%) | 0% | 0 | Common Stock | |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 84,745 | 85,185 (0%) | 0% | 0 | Common Stock | |
| James Sapirstein | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 300,000 | 300,000 (1%) | 1% | 0 | Common Stock | |
| Sarah M. Romano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
| Mary Theresa Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 84,745 | 84,745 (0%) | 0% | 0 | Common Stock | |
| David Andrew Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 84,745 | 90,778 (0%) | 0% | 0 | Common Stock | |
| Sarah M. Romano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| James E. Pennington | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 7,500 | 7,500 | - | - | Stock option (right to buy) | |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| James Sapirstein | Director, PRES, CEO & CHAIRMAN OF BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Mary Theresa Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| Vern Lee Schramm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Gregory Oakes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| Mary Theresa Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 10,310 | 10,310 | - | - | Stock option (right to buy) | |
| James E. Pennington | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2021 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| James Sapirstein | Director, PRES, CEO & CHAIRMAN OF BOARD | Other type of transaction at price $ 0.00 per share. | 30 Jun 2021 | 900,000 | 300,000 | - | - | Stock options (right to buy) | |
| James Sapirstein | Director, PRES, CEO & CHAIRMAN OF BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 900,000 | 900,000 | - | - | Stock options (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 35,006 | 35,006 | - | - | Stock option (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 30 Jun 2021 | 35,006 | 0 | - | - | Stock option (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 30 Jun 2021 | 250,000 | 0 | - | - | Stock option (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 250,000 | 250,000 | - | - | Stock option (right to buy) | |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 41,237 | 41,237 | - | - | Options (right to buy) | |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 41,237 | 41,237 | - | - | Options (right to buy) | |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 41,237 | 41,237 | - | - | Options (right to buy) | |
| Vern Lee Schramm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 41,237 | 41,237 | - | - | Options (right to buy) | |
| Gregory Oakes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 41,237 | 41,237 | - | - | Options (right to buy) | |
| James E. Pennington | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 300,000 | 300,000 | - | - | Stock option (right to buy) | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 46 | 46 | - | - | Series B Convertible Preferred Stock | |
| Edward J. Borkowski | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Jul 2020 | 100,000 | 0 | - | - | 9.0% Senior Convertible Promissory Note | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 25,774 | 25,774 | - | - | Exchange Warrants | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 230,602 | 230,602 | - | - | Series B Warrants | |
| James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 64,935 | 64,935 | - | - | Series B Warrants | |
| James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 12 | 12 | - | - | Series B Convertible Preferred Stock | |
| James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 1,200,000 | 1,200,000 | - | - | Stock options (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 35,006 | 35,006 | - | - | Stock option (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 250,000 | 250,000 | - | - | Stock option (right to buy) | |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 16 Jul 2020 | 35,006 | 300,000 | - | - | Stock option (right to buy) | |
| Gregory Oakes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2020 | 60,000 | 60,000 | - | - | Options | |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 80,000 | 80,000 | - | - | Options | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 80,000 | 80,000 | - | - | Options | |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 80,000 | 80,000 | - | - | Options | |
| Johan M. Spoor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 80,000 | 80,000 | - | - | Options | |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 80,000 | 80,000 | - | - | Options | |
| Charles J. Casamento | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Mar 2020 | 9,000 | 116,998 (0%) | 0% | 0 | Common Stock | |
| Charles J. Casamento | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Mar 2020 | 9,000 | 107,998 (0%) | 0% | 0 | Common Stock | |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 11 Mar 2020 | 14,584 | 108,584 (0%) | 0% | 0.6 | 8,750 | Common Stock |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 11 Mar 2020 | 8,414 | 116,998 (0%) | 0% | 1.0 | 8,751 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 3.63 per share. | 11 Mar 2020 | 2,755 | 106,296 (0%) | 0% | 3.6 | 10,001 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 4.74 per share. | 11 Mar 2020 | 264 | 101,034 (0%) | 0% | 4.7 | 1,251 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 4.74 per share. | 11 Mar 2020 | 770 | 100,770 (0%) | 0% | 4.7 | 3,650 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 11 Mar 2020 | 8,414 | 132,049 (0%) | 0% | 1.0 | 8,751 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 11 Mar 2020 | 14,584 | 123,635 (0%) | 0% | 0.6 | 8,750 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 3.99 per share. | 11 Mar 2020 | 2,507 | 103,541 (0%) | 0% | 4.0 | 10,003 | Common Stock |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 11 Mar 2020 | 8,414 | 90,498 (0%) | 0% | 1.0 | 8,751 | Common Stock |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 11 Mar 2020 | 14,584 | 82,084 (0%) | 0% | 0.6 | 8,750 | Common Stock |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 4.74 per share. | 10 Mar 2020 | 1,319 | 403,443 (1%) | 0% | 4.7 | 6,252 | Common Stock |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 4.74 per share. | 10 Mar 2020 | 6,330 | 409,773 (1%) | 0% | 4.7 | 30,004 | Common Stock |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 10 Mar 2020 | 8,414 | 402,124 (1%) | 0% | 1.0 | 8,751 | Common Stock |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 10 Mar 2020 | 14,584 | 393,710 (1%) | 0% | 0.6 | 8,750 | Common Stock |
| Daniel Schneiderman | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2020 | 335,006 | 335,006 | - | - | Options | |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 31 Dec 2019 | 7,500 | 94,000 (0%) | 0% | 1.0 | 7,800 | Common Stock |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 31 Dec 2019 | 7,500 | 100,000 (0%) | 0% | 1.0 | 7,800 | Common Stock |
| Vern Lee Schramm | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 31 Dec 2019 | 7,500 | 67,500 (0%) | 0% | 1.0 | 7,800 | Common Stock |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 20 Dec 2019 | 7,500 | 379,126 (1%) | 0% | 1.0 | 7,800 | Common Stock |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2019 | 51,547 | 103,094 | - | - | Warrants | |
| James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2019 | 300,000 | 300,000 | - | - | Options | |
| James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2019 | 200,000 | 200,000 (0%) | 0% | - | Common Stock | |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 30 Sep 2019 | 7,500 | 86,500 (0%) | 0% | 0.6 | 4,500 | Common |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 30 Sep 2019 | 7,500 | 371,626 (1%) | 0% | 0.6 | 4,500 | Common Stock |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 30 Sep 2019 | 7,500 | 92,500 (0%) | 0% | 0.6 | 4,500 | Common Stock |
| Vern Lee Schramm | Director | Grant, award, or other acquisition of securities at price $ 0.60 per share. | 30 Sep 2019 | 7,500 | 60,000 (0%) | 0% | 0.6 | 4,500 | Common Stock |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 30 Jun 2019 | 7,500 | 79,000 (0%) | 0% | 1.7 | 12,750 | Common |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 30 Jun 2019 | 7,500 | 364,126 (1%) | 0% | 1.7 | 12,750 | Common Stock |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 30 Jun 2019 | 7,500 | 85,000 (0%) | 0% | 1.7 | 12,750 | Common Stock |
| Vern Lee Schramm | Director | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 30 Jun 2019 | 7,500 | 52,500 (0%) | 0% | 1.7 | 12,750 | Common Stock |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 30,000 | 30,000 | - | - | Options | |
| James E. Pennington | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 110,000 | 110,000 | - | - | Stock option (right to buy) | |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 30,000 | 30,000 | - | - | Options | |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 30,000 | 30,000 | - | - | Options | |
| Vern Lee Schramm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 30,000 | 30,000 | - | - | Options | |
| Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 2.42 per share. | 31 Mar 2019 | 7,500 | 71,500 (0%) | 0% | 2.4 | 18,150 | Common Stock |
| Edward J. Borkowski | Director | Grant, award, or other acquisition of securities at price $ 2.42 per share. | 31 Mar 2019 | 7,500 | 356,626 (1%) | 0% | 2.4 | 18,150 | Common Stock |
| Alastair James Riddell | Director | Grant, award, or other acquisition of securities at price $ 2.42 per share. | 31 Mar 2019 | 7,500 | 77,500 (0%) | 0% | 2.4 | 18,150 | Common Stock |
| Vern Lee Schramm | Director | Grant, award, or other acquisition of securities at price $ 2.42 per share. | 31 Mar 2019 | 7,500 | 45,000 (0%) | 0% | 2.4 | 18,150 | Common Stock |
| Charles J. Casamento | None | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 28 Dec 2018 | 9,000 | 56,500 (0%) | 0% | 1.4 | 12,690 | Common Stock |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 1.29 per share. | 28 Dec 2018 | 7,500 | 64,000 (0%) | 0% | 1.3 | 9,675 | Common Stock |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 1.29 per share. | 28 Dec 2018 | 7,500 | 349,126 (1%) | 0% | 1.3 | 9,675 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 1.29 per share. | 28 Dec 2018 | 7,500 | 70,000 (0%) | 0% | 1.3 | 9,675 | Common Stock |
| Johan M. Spoor | Director, PRESIDENT AND CEO | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 28 Dec 2018 | 38,583 | 338,617 (1%) | 0% | 1.3 | 49,969 | Common Stock |
| Maged Shenouda | Director, CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 28 Dec 2018 | 20,000 | 62,500 (0%) | 0% | 1.3 | 26,214 | Common Stock |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 1.29 per share. | 28 Dec 2018 | 7,500 | 37,500 (0%) | 0% | 1.3 | 9,675 | Common Stock |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 2.57 per share. | 28 Sep 2018 | 7,500 | 47,500 (0%) | 0% | 2.6 | 19,275 | Common Stock |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 2.57 per share. | 28 Sep 2018 | 7,500 | 341,626 (2%) | 0% | 2.6 | 19,275 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 2.57 per share. | 28 Sep 2018 | 7,500 | 62,500 (0%) | 0% | 2.6 | 19,275 | Common Stock |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 2.57 per share. | 28 Sep 2018 | 7,500 | 30,000 (0%) | 0% | 2.6 | 19,275 | Common Stock |
| James E. Pennington | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 75,000 | 75,000 | - | - | Options | |
| Johan M. Spoor | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 200,000 | 300,034 (1%) | 1% | 0 | Common Stock | |
| Maged Shenouda | Director, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 100,000 | 100,000 | - | - | Options | |
| Daniel Dupret | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Daniel Dupret | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 60,000 | 60,000 | - | - | Options | |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2018 | 7,500 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2018 | 7,500 | 334,126 (1%) | 0% | 0 | Common Stock | |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2018 | 7,500 | 55,000 (0%) | 0% | 0 | Common Stock | |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2018 | 7,500 | 22,500 (0%) | 0% | 0 | Common Stock | |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 3.14 per share. | 29 Mar 2018 | 7,500 | 32,500 (0%) | 0% | 3.1 | 23,550 | Common Stock |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 3.14 per share. | 29 Mar 2018 | 7,500 | 305,446 (2%) | 0% | 3.1 | 23,550 | Common Stock |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 3.14 per share. | 29 Mar 2018 | 7,500 | 47,500 (0%) | 0% | 3.1 | 23,550 | Common Stock |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 3.14 per share. | 29 Mar 2018 | 7,500 | 15,000 (0%) | 0% | 3.1 | 23,550 | Common Stock |
| Edward J. Borkowski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 11 Jan 2018 | 13,680 | 305,446 (2%) | 0% | 2.5 | 34,200 | Common Stock |
| Edward J. Borkowski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 11 Jan 2018 | 13,680 | 319,126 (2%) | 0% | 2.5 | 34,200 | Common Stock |
| Edward J. Borkowski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2018 | 13,680 | 0 | - | - | Warrants | |
| Edward J. Borkowski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2018 | 8,640 | 28,474 | - | - | Warrants | |
| Edward J. Borkowski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2018 | 13,680 | 0 | - | - | Warrants | |
| Edward J. Borkowski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 11 Jan 2018 | 8,640 | 291,766 (2%) | 0% | 2.5 | 21,600 | Common Stock |
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2017 | 7,500 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2017 | 7,500 | 305,446 (2%) | 0% | 0 | Common Stock | |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2017 | 7,500 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Vern Lee Schramm | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2017 | 7,500 | 7,500 (0%) | 0% | 0 | Common Stock | |
| Johan M. Spoor | Director, PRESIDENT AND CEO | 10 Nov 2017 | 100,000 | 100,034 (0%) | 0% | 1 | 100,000 | Common Stock | |
| Johan M. Spoor | Director, PRESIDENT AND CEO | 10 Nov 2017 | 100,000 | 200,000 | - | - | Options | ||
| Charles J. Casamento | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2017 | 17,500 | 17,500 (0%) | 0% | 0 | Common Stock | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2017 | 22,500 | 275,626 (2%) | 0% | 0 | Common Stock | |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2017 | 22,500 | 32,500 (0%) | 0% | 0 | Common Stock | |
| Maged Shenouda | Director, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2017 | 22,500 | 42,500 (0%) | 0% | 0 | Common Stock | |
| Maged Shenouda | Director, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2017 | 100,000 | 100,000 | - | - | Options | |
| Edward J. Borkowski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 30,000 | 30,000 | - | - | Options | |
| Alastair James Riddell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 30,000 | 30,000 | - | - | Options | |
| Johan M. Spoor | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 100,000 | 100,000 | - | - | Options | |
| Maged Shenouda | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 30,000 | 30,000 | - | - | Options |